IDH1 and astrocytoma (excluding glioblastoma): Although not specific, TP53 mutations are more frequently seen in astrocytoma, IDH-mutant (more than 90% of cases) and, like ATRX mutations, also in diffuse hemispheric glioma, H3 G34-mutant (90%).